These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arylamine N-acetyltransferases: from structure to function. Sim E; Walters K; Boukouvala S Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144 [TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function. Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167 [TBL] [Abstract][Full Text] [Related]
4. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase. Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984 [TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Sim E; Abuhammad A; Ryan A Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436 [TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferases - of mice, men and microorganisms. Upton A; Johnson N; Sandy J; Sim E Trends Pharmacol Sci; 2001 Mar; 22(3):140-6. PubMed ID: 11239577 [TBL] [Abstract][Full Text] [Related]
7. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid. Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803 [TBL] [Abstract][Full Text] [Related]
8. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012 [TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656 [TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. Payton M; Auty R; Delgoda R; Everett M; Sim E J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365 [TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferases: what we learn from genes and genomes. Boukouvala S; Fakis G Drug Metab Rev; 2005; 37(3):511-64. PubMed ID: 16257833 [TBL] [Abstract][Full Text] [Related]
12. Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site. Abuhammad AM; Lowe ED; Fullam E; Noble M; Garman EF; Sim E Protein Cell; 2010 Apr; 1(4):384-392. PubMed ID: 21203950 [TBL] [Abstract][Full Text] [Related]
13. Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages. Abuhammad A; Fullam E; Lowe ED; Staunton D; Kawamura A; Westwood IM; Bhakta S; Garner AC; Wilson DL; Seden PT; Davies SG; Russell AJ; Garman EF; Sim E PLoS One; 2012; 7(12):e52790. PubMed ID: 23285185 [TBL] [Abstract][Full Text] [Related]
14. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis. Sandy J; Holton S; Fullam E; Sim E; Noble M Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451 [TBL] [Abstract][Full Text] [Related]
15. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis. Fullam E; Kawamura A; Wilkinson H; Abuhammad A; Westwood I; Sim E Protein J; 2009 Aug; 28(6):281-93. PubMed ID: 19636684 [TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974 [TBL] [Abstract][Full Text] [Related]
18. The pharmacogenetics of NAT: structural aspects. Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400 [TBL] [Abstract][Full Text] [Related]
19. The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity. Mushtaq A; Payton M; Sim E J Biol Chem; 2002 Apr; 277(14):12175-81. PubMed ID: 11799105 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. Sandy J; Mushtaq A; Holton SJ; Schartau P; Noble ME; Sim E Biochem J; 2005 Aug; 390(Pt 1):115-23. PubMed ID: 15869465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]